Evidence map›Paper›PMID 33454910›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2021

High-density versus low-density mapping in ablation of atypical atrial flutter.

J C Balt, M N Klaver, B K Mahmoodi, V F van Dijk, M C E F Wijffels, L V A Boersma

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Atypical atrial flutter ablation: clinical practice on patient selection, mapping, ablation strategies, and procedural endpoints-results from a European Heart Rhythm Association survey.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  3. Article
  4. Outcome after ablation of atypical atrial flutter: Is induction a feasible approach?International journal of cardiology. Heart & vasculature · 2024
    Article
  5. Article
  6. Clinical impact of high-density mapping on the acute and long term outcome of atypical atrial flutter ablations.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  7. Atypical atrial flutter catheter ablation in the era of high-density mapping.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J C BaltSt. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands. j.balt@antoniusziekenhuis.nl.ORCID http://orcid.org/0000-0002-7880-3730
M N KlaverSt. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands.
B K MahmoodiSt. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands.
V F van DijkSt. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands.
M C E F WijffelsSt. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands.
L V A BoersmaSt. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands.
St. Antonius Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAblation of atypical atrial flutter (AAFL) can be challenging. High-density (HD) mapping of ablation targets may potentially increase procedural success and freedom from recurrent AAFL. The objective of the present study was to explore whether employing HD mapping leads to a more favorable outcome in ablation of AAFL.

methodsWe compared baseline and procedural characteristics, procedural success, safety and outcome of mapping and ablation of atypical flutter in three groups. (1) HD Grid catheter + the high-density electroanatomical mapping (EAM) system EnSite Precision; (2) standard 10-pole circular mapping catheter (CMC) + EnSite Precision; (3) CMC + the low-density EnSite Velocity EAM. Voltage and propagation maps were constructed.

resultsMapping of 142 AAFL in 82 patients was performed. Acute ablation success was 78%, 68%, and 51% in groups 1, 2, and 3 (p = 0.037 between group 1 and 3, non-significant between groups otherwise). Moreover, 8%, 27%, and 36% of flutters were unmappable in groups 1, 2, and 3, respectively (p < 0.05 between group 1 and both groups 2 and 3). AAFL recurrence at 1-year FU was 26%, 36%, and 62% in groups 1, 2, and 3 (p = 0.007 between groups 1 and 3, p = 0.05 between groups 2 and 3). AAFL-free survival was significantly higher in patients mapped with Precision than with Velocity (p = 0.011). No strokes or mortality occurred within 30 days.

conclusionsAcute procedural success of ablation of atypical atrial flutter is higher and the number of unmappable flutters is lower using the HD Grid mapping catheter in combination with the high-density EnSite Precision system, as compared to a decapolar circular mapping catheter and the low-density EnSite Velocity EAM system. This may lead to increased freedom from recurrent AAFL at 1 year. HD mapping is safe.

Indexed as

Atrial FlutterCatheter AblationArrhythmias, CardiacHumansTime FactorsTreatment OutcomeAblationAdvisor HD GridAtypical atrial flutterCircular mapping catheterEnSite PrecisionEnSite VelocityHigh-density mapping

Identifiers

PMID33454910
OpenAlexW3124485309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.